Game Plan Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82K Hold
30
﹤0.01% 263
2025
Q4
$1.62K Hold
30
﹤0.01% 274
2025
Q3
$1.35K Hold
30
﹤0.01% 290
2025
Q2
$1.39K Hold
30
﹤0.01% 290
2025
Q1
$1.83K Hold
30
﹤0.01% 284
2024
Q4
$1.69K Hold
30
﹤0.01% 300
2024
Q3
$1.55K Hold
30
﹤0.01% 319
2024
Q2
$1.25K Hold
30
﹤0.01% 320
2024
Q1
$1.63K Hold
30
﹤0.01% 354
2023
Q4
$1.54K Buy
+30
New +$1.57K ﹤0.01% 347

Other funds holding BMY

Game Plan Financial Advisors's BMY Position: Q1 2026 in Review

Game Plan Financial Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 30 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

Game Plan Financial Advisors first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.83K in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Game Plan Financial Advisors held 30 shares of Bristol-Myers Squibb worth $1.82K as of Q1 2026.
  • Game Plan Financial Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q1 2026, its #263 holding.
  • Game Plan Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Game Plan Financial Advisors's Bristol-Myers Squibb position peaked at $1.83K in Q1 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Game Plan Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.